Premium
Experimental Evaluation of the Dialdehyde Starch Preserved Bovine Internal Mammary Artery as a Small Diameter Arterial Substitute
Author(s) -
WELZ ARMIN,
TRIEFENBACH RALPH,
MURRMANN GABI,
GRENZNER STEFAN,
HAMMER CLAUS
Publication year - 1992
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/j.1540-8191.1992.tb00792.x
Subject(s) - thrombogenicity , medicine , femoral artery , mammary artery , platelet , artery , polytetrafluoroethylene , surgery , urology , materials science , metallurgy
A bstract A canine femoral artery model was used for evaluation of a dialdehyde starch preserved bovine internal mammary artery (BIMA) (3 and 4 mm internal diameter) in comparison to a polytetrafluoroethylene (PTFE) graft. The study comprised three groups for a 2‐hour (n = 7, 3 mm), 3‐month (n = 10, 4 mm), and 6‐month (n = 10, 4 mim) follow‐up. The thrombogenicity of the grafts was measured after 2 hours and 3 months using chromium 51 labeled autologous platelets. In addition, compliance studies were done. To control the wall stability of the xenografts, the collagen content before implantation and after explantation was examined together with the diameter of the grafts. Healing characteristics were studied using appropriate histologic methods. The acute platelet adhesion rate (2 hours) of the BIMA graft was 181 ± 69 × 10 4 platelets/mm 2 as compared to 57 ± 43 × 10 4 for PTFE (p < 0.05, t‐test). However, after 3 months the thrombogenicity of the biograft had decreased whereas the platelet count at the PTFE graft had increased (BIMA: 79 ± 48 × 10 4 ; PTFE: 179 ± 102 × 10 4 , p < 0.05). At implantation, the compliance of the BIMA graft was 0.028%± 0.009% per mmHg as compared to 0.06%± 0.0025% of the femoral artery. The PTFE graft was uncompliant (0.008 ± 0.005). After 6 months, the compliance of the femoral artery had decreased to 0.039%± 0.013% per mmHg, which was now well matched to the nearly unchanged compliance of the biograft (0.0027 ± 0.005). The external diameters and the collagen contents of the xenografts remained unchanged. In contrast to PTFE, the xenografts developed no diameter‐reducing neointima. After 6 months, six out of ten BIMA grafts and only two out often PTFE grafts remained patent.